Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation

This study has been completed.
Sponsor:
Collaborator:
Novartis
Information provided by:
The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT00264420
First received: December 6, 2005
Last updated: December 20, 2010
Last verified: December 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Estimated Primary Completion Date: No date given